News
CVS Caremark will stop covering Eli Lilly’s Zepbound. Wegovy, the GLP-1 medication to treat obesity from Lilly competitor ...
Agency will require a Limitation of Use section in the prescribing information of all extended-release ADHD stimulants ...
Dr. Mahsa Tehrani discusses how patients use medication to help them lose weight on 'America Reports.' ...
Top executives ignored warnings that the company was not sufficiently prepared for the launch of its weight-loss drug Wegovy, ...
GLP-1 agonists like Wegovy, Ozempic, and Mounjaro might benefit heart and brain health—but research suggests they might also ...
Kate Beckinsale addressed her dramatic weight loss after a fan weighed in on her appearance via social media. On Tuesday, the ...
Keeping Up With the Kardashians' star Khloé Kardashian has been open about her health journey over the years. Here's ...
Both semaglutide and tirzepatide for type 2 diabetes and weight loss are GLP-1 agonists, meaning they mimic the hormone.
Study finds the GLP-1 drug liraglutide reduced migraine days by almost 50% in patients with obesity, with quality of life ...
14hon MSN
Kylie Kelce said she's been feeding her husband, Jason Kelce, doughnuts and other treats amid his weight-loss competition ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback